| An SI Board Since May 1996 |
| Posts |
SubjectMarks |
Bans |
| 46 |
2 |
0
|
| Emcee:
Steve
|
Type:
Unmoderated
|
|
The following was taken from the company's most recent 10K:
"ImmuCell Corporation (the "Company") is a biotechnology company that primarily develops, manufactures and markets milk-derived passive antibody products to prevent and/or treat gastrointestinal infections in both humans and animals. Using its core technology, the Company has developed proprietary methods for the production of commercial quantities of pathogen-specific antibodies from cows' milk. FIRST DEFENSE{R}, which has been approved by the United States Department of Agriculture ("USDA"), is the first product using this technology to be commercialized by the Company. Currently, this product is the only USDA-licensed, bivalent (effective on combatting two different infectious agents) scours preventive product in capsule form available on the market. The Company is investing in research and development that could lead to the commercialization of new products incorporating these proprietary methods for the prevention and/or treatment of gastrointestinal infections in humans.
From its inception in 1982, the Company has engaged in the research and development of both infectious disease diagnostic tests and products for therapeutic and preventive uses against certain infectious diseases in animals and humans. Since 1991, this product development effort has focused more principally on gastrointestinal diseases. Recently, the Company has diversified its product development pipeline in two significant ways. First, the Company has utilized the knowledge gained developing a passive antibody product to treat or prevent a gastrointestinal infection caused by CRYPTOSPORIDIUM PARVUM to develop a method to detect the presence of this dangerous parasite in public water supplies. The Company intends to begin beta testing in 1996 to evaluate the performance of the method under actual field conditions. Secondly, the Company has utilized both its expertise in processing proteins from cows' milk and its exclusive world-wide license to certain purification technology to develop a process to separate specialty proteins from cheese whey."
|
|
|
